| Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic P Karlsson, AO Nakitanda, L Löfling, CE Cesta PloS one 16 (8), e0253944, 2021 | 37 | 2021 |
| Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study L Löfling, A Karimi, F Sandin, S Bahmanyar, H Kieler, M Lambe, ... Acta oncologica 58 (11), 1618-1627, 2019 | 32 | 2019 |
| Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer A Chang, E Botteri, RD Gillis, L Löfling, CP Le, AI Ziegler, NC Chung, ... Science Translational Medicine 15 (693), eadf1147, 2023 | 24 | 2023 |
| β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis LL Løfling, NC Støer, EK Sloan, A Chang, S Gandini, G Ursin, E Botteri British Journal of Cancer 127 (6), 1086-1096, 2022 | 21 | 2022 |
| Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer L Löfling, A Sundström, H Kieler, S Bahmanyar, M Linder Clinical Epidemiology, 133-143, 2019 | 13 | 2019 |
| Temporal trends in lung cancer survival: a population-based study L Löfling, S Bahmanyar, H Kieler, M Lambe, G Wagenius Acta Oncologica 61 (5), 625-631, 2022 | 11 | 2022 |
| Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns AO Nakitanda, P Karlsson, L Löfling, CE Cesta, I Odsbu BMC infectious diseases 22 (1), 492, 2022 | 10 | 2022 |
| Maternal and infant characteristics: differences and similarities between the Nordic countries and the US L Löfling, G Bröms, S Bahmanyar, H Kieler Clinical epidemiology, 285-294, 2016 | 9 | 2016 |
| Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post‐authorization safety cohort study conducted in Europe and in … V Ehrenstein, K Huang, J Kahlert, S Bahmanyar, P Karlsson, L Löfling, ... Pharmacoepidemiology and Drug Safety 30 (6), 758-769, 2021 | 7 | 2021 |
| Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study LL Löfling, NC Støer, BK Andreassen, G Ursin, E Botteri Breast Cancer Research 25 (1), 101, 2023 | 5 | 2023 |
| Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women L Løfling, NC Støer, S Nafisi, G Ursin, S Hofvind, E Botteri European Journal of Epidemiology 38 (4), 413-426, 2023 | 4 | 2023 |
| Antibiotic use prior to a lung cancer diagnosis: a population-based study L Löfling, S Bahmanyar, H Kieler, M Lambe, G Wagenius Cancer Causes & Control 32, 597-607, 2021 | 4 | 2021 |
| Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study C Sanjinez, E Botteri, NC Støer, LL Löfling Lung Cancer 179, 107187, 2023 | 2 | 2023 |
| Lung cancer registries in Denmark, Finland, Norway and Sweden: a comparison and proposal for harmonization A Gouliaev, TR Rasmussen, N Malila, L Fjellbirkeland, L Löfling, ... Acta Oncologica 62 (1), 1-7, 2023 | 2 | 2023 |
| Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study PJ Arena, K Huang, L Löfling, S Bahmanyar, J Mo, SE Schachterle, ... Pharmacoepidemiology and drug safety 32 (5), 592-596, 2023 | 1 | 2023 |
| Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: a Swedish national register study L Löfling, M Linder, C Ekstrand, H Cherif, H Kieler, S Bahmanyar Thrombosis Research 160, 27-31, 2017 | 1 | 2017 |
| Low-dose aspirin and prevention of colorectal cancer: evidence from a nationwide registry-based cohort in Norway S Nafisi, NC Støer, MB Veierød, KR Randel, G Hoff, L Löfling, C Bosetti, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | | 2022 |
